COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 3004: Articles 30031-30040  | Next

Lack of Antiviral Activity of Darunavir against SARS-CoV-2
De Meyer, S., Bojkova, D., Cinati, J., Van Damme, E., Buyck, C., Van Loock, M., Woodfall, B., Ciesek, S.
10.1101/2020.04.03.20052548 — Posted: 2020-04-08
Interaction between malarial transmission and BCG vaccination with COVID-19 incidence in the world map: A changing landscape human immune system?
Goswami, R. P., Mittal, D. K., Goswami, R. P.
10.1101/2020.04.03.20052563 — Posted: 2020-04-08
Optimize Clinical Laboratory Diagnosis of COVID-19 from Suspect Cases by Likelihood Ratio of SARS-CoV-2 IgM and IgG antibody
Yangchun, F.
10.1101/2020.04.07.20053660 — Posted: 2020-04-08
Derivation of the effective reproduction number R for COVID-19 in relation to mobility restrictions and confinement
Arenas, A., Cota, W., Gomez-Gardenes, J., Gomez, S., Granell, C., Matamalas, J. T., Soriano-Panos, D., Steinegger, B.
10.1101/2020.04.06.20054320 — Posted: 2020-04-08
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters
Ioannidis, J. P. A., Axfors, C., Contopoulos-Ioannidis, D. G.
10.1101/2020.04.05.20054361 — Posted: 2020-04-08 Discussion: Onsite
Use Crow-AMSAA Method to predict the cases of the Coronavirus 19 in Michigan and U.S.A
Wang, Y.
10.1101/2020.04.03.20052845 — Posted: 2020-04-08
The basic reproduction number and prediction of the epidemic size of the novel coronavirus (COVID-19) in Shahroud, Iran
Khosravi, A., Chaman, R., Rohani-Rasaf, M., Zare, F., Mehravaran, S., Emamian, M. H.
10.1101/2020.04.04.20052308 — Posted: 2020-04-08
Social distancing to slow the U.S. COVID-19 epidemic: an interrupted time-series analysis
Siedner, M. J., Harling, G., Reynolds, Z., Gilbert, R. F., Venkataramani, A., Tsai, A. C.
10.1101/2020.04.03.20052373 — Posted: 2020-04-08 Discussion: Offsite
Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia
Blasco, M. L., Buesa, J., Colomina, J., Forner, M. J., Galindo, M. J., Navarro, J., Noceda, J., Redon, J., Signes-Costa, J., Navarro, D.
10.1101/2020.04.06.20052522 — Posted: 2020-04-08
Defining high-value information for COVID-19 decision-making
COVID-19 Statistics, Policy modeling, and Epidemiology Collective, , Salomon, J. A.
10.1101/2020.04.06.20052506 — Posted: 2020-04-08 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).